Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 3173 entries
View as:

The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD

Phase: N/A Priority: Normal
NCT ID: NCT00163059 Org: User:
Start: 05/31/04 End: 12/31/05 Due: 12/31/06

Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00699374 Org: User:
Start: 07/31/08 End: 12/31/11 Due: 12/31/12

A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04628793 Org: User:
Start: 03/16/21 End: 08/25/21 Due: 08/25/22

A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01422187 Org: User:
Start: 08/31/11 End: 09/30/14 Due: 09/30/15

A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT06079320 Org: User:
Start: 12/08/23 End: 09/30/24 Due: 09/30/25

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

Phase: N/A Priority: Normal
NCT ID: NCT01321463 Org: User:
Start: 05/31/11 End: 06/30/12 Due: 06/30/13

A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03854227 Org: User:
Start: 03/14/19 End: 04/27/22 Due: 04/27/23

Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC

Phase: N/A Priority: Normal
NCT ID: NCT05505175 Org: User:
Start: 05/30/22 End: 05/02/23 Due: 05/02/24

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Phase: N/A Priority: Normal
NCT ID: NCT01154140 Org: User:
Start: 01/13/11 End: 11/30/16 Due: 11/30/17

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01465763 Org: User:
Start: 04/30/12 End: 05/31/15 Due: 05/31/16

Study to Assess the Effectiveness and Safety of FLECTOR Patch for Treatment of Acute Back Strain

Phase: N/A Priority: Normal
NCT ID: NCT01054820 Org: User:
Start: 01/31/10 End: 03/31/10 Due: 03/31/11

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03041792 Org: User:
Start: 02/20/17 End: 01/16/18 Due: 01/16/19

Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00444548 Org: User:
Start: 05/31/07 End: 07/31/07 Due: 07/31/08

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

Phase: N/A Priority: Normal
NCT ID: NCT01077973 Org: User:
Start: 03/31/10 End: 10/31/10 Due: 10/31/11

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00094055 Org: User:
Start: 09/30/04 End: 01/31/09 Due: 01/31/10

A Study Of PF-04449913 In Select Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00953758 Org: User:
Start: 03/03/10 End: 02/27/13 Due: 02/27/14

A Study In Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00726752 Org: User:
Start: 07/31/08 End: 04/30/10 Due: 04/30/11

A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract

Phase: N/A Priority: Normal
NCT ID: NCT01844323 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01938144 Org: User:
Start: 04/30/16 End: 11/30/16 Due: 11/30/17

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01720537 Org: User:
Start: 07/31/12 End: 10/31/13 Due: 10/31/14

Actigraphy Improvement With Voxelotor (ActIVe) Study

Phase: N/A Priority: Normal
NCT ID: NCT04400487 Org: User:
Start: 12/21/20 End: 09/13/22 Due: 09/13/23

Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib

Phase: N/A Priority: Normal
NCT ID: NCT02131298 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT00724971 Org: User:
Start: 07/04/08 End: 03/10/10 Due: 03/10/11

A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03273842 Org: User:
Start: 10/27/17 End: 07/25/18 Due: 07/25/19

A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002068 Org: User:
Start: - End: - Due: -